Relationship of Specialty Diets to the Severity of Symptoms Associated with Autism by Lee, Rachele
University of North Dakota
UND Scholarly Commons
Nursing Capstones Department of Nursing
12-28-2015
Relationship of Specialty Diets to the Severity of
Symptoms Associated with Autism
Rachele Lee
Follow this and additional works at: https://commons.und.edu/nurs-capstones
This Independent Study is brought to you for free and open access by the Department of Nursing at UND Scholarly Commons. It has been accepted for
inclusion in Nursing Capstones by an authorized administrator of UND Scholarly Commons. For more information, please contact
zeineb.yousif@library.und.edu.
Recommended Citation
Lee, Rachele, "Relationship of Specialty Diets to the Severity of Symptoms Associated with Autism" (2015). Nursing Capstones. 222.
https://commons.und.edu/nurs-capstones/222
Running Head: AUTISM AND DIET                                      1 
 
 
 
 
 
 
Relationship of Specialty Diets to the Severity of Symptoms Associated with Autism 
 
by 
 
Rachele Lee 
 
Bachelors of Science in Nursing, East Stroudsburg University, 2004 
 
 
An Independent Study 
Submitted to the Graduate Faculty 
of the  
 
University of North Dakota 
in partial fulfillment of the requirements 
for the degree of 
Master’s of Science in Nursing 
 
 
 
Grand Forks, North Dakota 
May 
2016 
 
 
 
AUTISM AND DIET   
 
2 
This independent study, submitted by Rachele Lee in partial fulfillment of the requirements for 
the Degree of Master of Science from the University of North Dakota, has been read by the 
faculty advisor under whom the work has been done and is hereby approved. 
  
       ____________________________________ 
         Faculty Advisor 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AUTISM AND DIET   
 
3 
PERMISSION 
 
Title  Relationship of Specialty Diets to the Severity of Symptoms Associated with  
  Autism 
 
Department  Nursing 
Degree  Master of Science 
 
In presenting this independent study in partial fulfillment of the requirements for a graduate 
degree from the University of North Dakota, I agree that the College of Nursing of this 
University shall make it freely available for inspection. I further agree that permission for 
extensive copying or electronic access for scholarly purposes may be granted by the professor 
who supervised my independent study work or, in her absence, by the chairperson of the 
department or the dean of the Graduate School. It is understood that any copying or publication 
or other use of this independent study or part thereof for financial gain shall not be allowed 
without my written permission. It is also understood that due recognition shall be given to me 
and to the University of North Dakota in any scholarly use which may be made of any material 
in my independent study. 
 
 
 
 
 
 
Signature ____________________________ 
 
 
Date _____________________________ 
 
 
 
 
 
 
 
 
AUTISM AND DIET   
 
4 
Abstract 
Problem – Autism is a complex umbrella disorder given to children or adults who experience a 
variety of similar symptoms, yet no concrete cause has been identified for those with the 
diagnosis. Treatment options are expensive and complex, and no single method has been proven 
effective for every child with autism. Some parents have utilized dietary intervention but existing 
evidence on its effectiveness isn’t widely studied or recommended by practitioners. 
Procedure – A literature review was conducted to determine the current evidence behind the 
implementation of a gluten-free casein-free (GFCF) diet and its effectiveness on the severity of 
symptoms associated with an autism diagnosis. 
Results – Findings are not 100% consistent with a positive outcome of GFCF dietary 
implementation in children with autism, yet 11 of the 15 studies examined did show 
improvements in a variety of behaviors or physiologic processes. 
Nursing Implications – Dissemination of findings to local pediatric practice offices and agencies 
would prove beneficial with the encouragement of recommending a GFCF dietary trial for 
children diagnosed with autism.   
Introduction 
 It is currently estimated by the Centers for Disease Control and Prevention (CDC) that 
one in 68 children are diagnosed with an autism spectrum disorder (ASD) (2016). Other sources 
estimate this number to be even higher, at one in 50 children diagnosed (National Vaccine 
Information Center, 2013). The autism prevalence rate among girls is approximately 1 in 189 and 
unfortunately 5 times more likely in boys with a rate of 1 in 42 (CDC, 2016). Although this 
number continues to increase, there is little known about the true etiologies or cures for the 
disorder (Elder, 2008). 
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 The CDC (2016) defines ASDs as “a group of developmental disabilities that can cause 
significant social, communication, and behavioral challenges.” Elder (2008) adds that children 
living with an ASD diagnosis can present with repetitive behaviors and “processing delays that 
can cause difficulties in responding to others, motor planning, and visual processing” (p. 584). 
Genius and Bouchard (2010) also note significant symptoms to include “significant aggression, 
tendencies toward self-injury and self-harm, irritability, as well as hyperactive and erratic 
behavior” (p. 114).  
 The exact cause of ASD is unknown but there is belief that a genetic susceptibility to 
environmental factors could play a major role. It is also hypothesized that immunologic and 
gastrointestinal permeability play a role in the neurologic and behavioral symptoms associated 
with autism (Mulloy et al, 2010). Many children with ASD will experience some form of chronic 
constipation or diarrhea, suggestive of gastrointestinal disorder. Although there has not been a 
proven cure, many studies are stating that removing both gluten and casein (a protein found in 
cow’s milk) from the diet of children with autism can lead to a decrease in the severity of 
symptoms associated with the disorder (Knivsberg, Reichelt, Hoien, & Nodland, 2002). 
Purpose 
 Many children with autism will endure years and years of traditional therapy in attempts 
to improve “typical” behavior and reduce symptoms related to their diagnosis (Hsu, Lin, Chen, 
Wang, & Wong, 2009). The average cost of treatment for many individuals on the spectrum is an 
outstanding $60,000-$70,000 PER YEAR for various therapies, schooling, and alternative 
treatment options (Parker-Pope, 2010). Treatment recommendations generally include 
educational intervention, physical and developmental therapy, and behavioral treatment (Elder, 
2008). Yet “there is increasing recognition that the expression of ASD in some sub-groups may 
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also include a number of additional elements beyond psychiatry that may be potentially relevant” 
(Whiteley et al, 2010, p.88). Diet changes are under scrutiny as a physical trigger for 
psychological symptoms. It is possible that dietary change can have a great impact on behavior 
and therefore lessen the amount of therapy or other treatments necessary, yet this form of 
alternative type therapy is not widely studied or utilized within the autism community. 
Significance 
 Autism rates are soaring among children with a current estimate that one in every 50-68 
children is diagnosed with an ASD. This is a 72% increase from 2007 when estimates were one 
in every 88 children diagnosed (National Vaccine Information Center, 2013). “For some time 
clinical experience has supported the existence of a functional relationship between the central 
nervous system (CNS) and the gastrointestinal (GI) tract, a paradigm known as the ‘brain-gut 
axis’” (Julio-Pieper, Bravo, Aliaga, & Gotteland, 2014, p. 1188). “The first ever formal 
description of autistic symptoms contains reference to GI symptoms and dietary issues being 
present in some cases” (Whiteley et al, 2013, p. 2).  
 The intestinal mucosa is the largest surface of interaction between internal body systems 
and the external environment. It’s dual functions include regulation of the absorption of water, 
electrolytes, and nutrients from the intestines into circulation, while at the same time preventing 
the penetration of harmful pathogens and toxins, including dietary antigens (Julio-Pieper et al, 
2014). The theory behind the removal of gluten and casein of a child with autism’s diet involves 
the belief that children with autism cannot break down the gluten and casein proteins completely 
or appropriately. This inappropriate breakdown results in opioid peptides that are able to leak 
through the intestinal wall (leaky gut syndrome), enter the bloodstream, cross the blood-brain 
barrier, and ultimately affect neurotransmission within the central nervous system (Elder, 2008). 
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Studies have shown that many children with autism suffer from gastrointestinal inflammation 
due to the ingestion of these proteins, which eventually leads to the leaky gut syndrome that 
allows the peptides to enter the bloodstream (Knivsberg et al, 2002).    
 The impaired neurotransmission in children with autism, as a result of ingesting gluten 
and/or casein products, is believed to attribute to difficulties in communication and use of 
language, affect attention and concentration, impair social integration and interaction, contribute 
to altered pain perception and lead to self-injurious behaviors, contribute to stereotypical or 
repetitive behaviors, impair motor coordination, and contribute to hyperactivity (Whiteley et al., 
2013). Therefore, it is possible that removing these proteins from the diet of a child with autism 
could lead to an improvement or elimination of some or all of his or her symptoms. 
Theoretical Framework 
 The framework for this study is based upon a physiological theory known as the leaky 
gut hypothesis, which correlates poor gut health and function to neurological symptoms 
specifically in children with an ASD (Lang, Hauser, & Reissmann, 2015). Oftentimes, children 
with autism will exhibit a variety of gastrointestinal disturbances. These may include one or all 
of the following: constipation, diarrhea, abdominal pain and/or abdominal bloating. Some 
parents’ even report that these symptoms began around the same time their child regressed and 
began experiencing autism symptoms (White, 2003).  
 The “GI tract works very closely with the immune system to maintain homeostasis and 
protects our body against microorganisms and foreign antigens” (Samsam, Ahangari, & Naser, 
2014, p. 9944). The intestinal lumen is lined by only a single layer of epithelial cells, which are 
responsible for preventing various intestinal contents from escaping the gut and entering the 
bloodstream. These epithelial cells are joined together by filaments forming tightly bound 
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intercellular junctions on their lateral walls (Liu, Li, & Neu, 2005). “The idea that the integrity of 
the intestinal mucosal lining, referred to as the intestinal mucosal barrier, is compromised in 
autism is embodied in the ‘leaky gut hypothesis.’ According to this hypothesis, the intestinal 
mucosa is abnormally permeable in autism” (White, 2003, p. 642). In other words, the junctions 
between the epithelial cells are compromised and are unable to properly regulate what may enter 
and escape the intestinal lumen. 
 The exact cause of this intestinal dysfunction isn’t clearly known but speculations have 
been made on a few different causes. One possible cause of intestinal inflammation and 
dysfunction seen in children with autism, and the primary focus of this project, is due to antigens 
in the diet. Gliadin is the peptide that is derived from gluten and is believed to cause or 
contribute to increased intestinal permeability the same way it affects those with Celiac Disease. 
Similarly, “children with cow’s milk allergy also exhibit inflammation of the intestinal lamina 
propria and partial villous atrophy after ingesting milk; inflammation is reversed when milk is 
excluded from the diet. Hence, milk proteins may also cause changes in gut permeability” 
(White, 2003, p. 643). 
 According to the leaky gut hypothesis, “it is proposed that gliadomorphins and 
casomorphins arising from the partial luminal digestion of dietary gliadin and casein, 
respectively, are absorbed through a leaky gut, enter into the CNS, and interfere with normal 
brain function because their functional properties mimic the opioid hormone beta-endorphin” 
(White, 2003, p. 646). Petra et al (2015, p. 985) also support this idea stating, “Neuro/immune-
active substances derived from the intestinal lumen can penetrate the gut mucosa, be transported 
by blood, cross the blood–brain barrier (BBB), and affect the CNS.” 
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 “GI abnormalities are often seen to correlate with the severity of the ASD behavioral 
problems and current literature favors a gut-brain interaction where GI abnormalities may be 
involved in the pathogenesis or severity of ASD” (Samsam et al, 2014, p. 9944). Due to this 
hypothesis, a diet free from the gluten and casein proteins is recommended to alleviate GI as well 
as neurologic or behavioral symptoms. 
Definitions 
Autism Spectrum Disorder (ASD) – “Autism spectrum disorder (ASD) and autism are both 
general terms for a group of complex disorders of brain development. These disorders are 
characterized, in varying degrees, by difficulties in social interaction, verbal and nonverbal 
communication and repetitive behaviors” (Autism Speaks, 2016). 
Casein – a phosphoprotein of mammal milk (Merriam-Webster, 2015). 
Celiac Disease – “an autoimmune disorder that can occur in genetically predisposed people 
where the ingestion of gluten leads to damage in the small intestine” (Celiac Disease Foundation, 
2016). 
Gluten – “a tenacious elastic protein substance especially of wheat flour that gives cohesiveness 
to dough” (Merriam-Webster, 2015). 
Lamina Propria – “a highly vascular layer of connective tissue under the basement membrane 
lining a layer of epithelium” (Merriam-Webster, n.d.). 
Leaky-Gut Syndrome – Impaired intestinal permeability leading to abnormal intestinal absorption 
(Pusponegoro, Ismael, Firmansyah, Sastroasmoro, & Vandenplas, 2015). 
Opioid – “Any of a group of endogenous neural polypeptides (as an endorphin or enkephalin) 
that bind especially to opiate receptors and mimic some of the pharmacological properties of 
opiates —called also opioid peptide” (Merriam-Webster, 2015). 
AUTISM AND DIET   
 
10 
Peptide – “Any of various amides that are derived from two or more amino acids by combination 
of the amino group of one acid with the carboxyl group of another and are usually obtained by 
partial hydrolysis of proteins” (Merriam-Webster, 2015). 
Process 
 The University of North Dakota’s Harley E. French Library of the Health Sciences was 
used to conduct a search of related literature. The CINAHL database was the initial database 
used when performing the search. According to the EBSCOhost website, CINAHL provides 
“hundreds of nursing and allied health journals” with “records dating back to 1937” (EBSCO 
Industries, 2013). PubMed was used as a secondary source of information. “PubMed is a free 
resource that is developed and maintained by the National Center for Biotechnology Information 
(NCBI), at the U.S. National Library of Medicine (NLM), located at the National Institutes of 
Health (NIH)” (NCBI, 2005). 
 When conducting the search in the CINAHL database the terms “autism” AND “gluten” 
AND “casein” were entered with the “find all my search terms” used as the search mode. This 
yielded 22 results found with publication dating back to the year 2000. After a brief overview, 
eight articles were reviewed in more detail and only two articles were found to be relevant to the 
project topic. A second search term was performed with the terms “gfcf autism.” This search 
revealed five results, four of which were included in the original search. The fifth article was 
reviewed in detail and determined to be pertinent to the project topic. 
 Another search was conducted through the PubMed database with the search term “gfcf 
autism” which yielded six results. Three articles were reviewed in detail and it was determined 
that only one was relevant. Subsequently the terms “autism and gluten and casein” were entered 
into the search field. This search yielded 53 results, seven of which were reviewed in detail and 
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three additional were determined to be relevant. A third search was entered into the PubMed 
database with the search term “gluten autism” which yielded 115 results. Thirteen articles were 
reviewed in detail and it was determined that eight articles were relevant, which concluded the 
search. 
 Article reference sections for both database searches were reviewed prior to making the 
final determination of relevant articles. It was found that references that appeared relevant had 
already been included in the original search results; therefore additional sources from references 
were not utilized. 
Review of the Literature 
 Specific studies regarding the elimination of gluten and casein from an autistic child’s 
diet are limited and many are now outdated. Fifteen studies were examined in detail with varying 
results. Many different symptoms were measured and varied from study to study. Some of these 
included communication, social isolation, eye contact, mutism, learning skills, hyperactivity, 
stereotypical activity, hygiene, panic attacks, self mutilation, gastrointestinal problems, social 
interaction, imagination, tantrums, anxiety, seizure activity, inattention, aloofness, need for 
routine, peer relationships, empathy, physical contact, language peculiarities, peculiar interests, 
sensory symptoms, and motor skills.  
 Four of the studies examined were case reports on a single child ranging in ages from 
three, to 23 years old and detailed his or her history and symptom improvement or resolution 
following a gluten-free or gluten and casein-free diet (Hsu, Lin, Chen, Wang, & Wong, 2009; 
Genius & Lobo, 2014; Herbert & Buckley, 2013; Genius & Bouchard, 2010). All four of the 
children described in these articles experienced positive improvements in autistic behaviors or 
complete resolution of symptoms leading to a complete recovery.  
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 Hsu et al (2009) followed one child aged 42 months at the initiation of the study who was 
diagnosed with autism, growth and developmental retardation, and CHARGE (Coloboma of the 
eye, Heart defects, Atresia of the choanae, Retardation of growth and/or development, Genital 
and/or urinary abnormalities, and Ear abnormalities and deafness) syndrome. The child was 
observed over an 11-month time span and data was collected throughout that time frame. 
Improvements in all areas of development were noted at the 11-month mark of follow-up. 
Weight percentiles were also measured, which were originally below the third percentile and had 
increased to approximately the 15th percentile by that time. Strengths of this article included the 
fact that objective developmental measurement tools were utilized before and after dietary 
intervention and included intermittent follow-up periods. Also, the length of time for follow up 
was significant, allowing for complete healing of the gastrointestinal system if gluten and/or 
casein proved a causative factor. Limitations included the fact that this was just a single observed 
case report and double blind observations before and after initiation of diet were not performed. 
Also, the child continued to receive physical, occupational, speech, and sensory integration 
therapies throughout dietary intervention, which could also have an effect on the final outcome. 
 Genius and Lobo (2014) reported on a now 23-year-old female with a longstanding 
history of auditory and visual hallucinations, along with gastrointestinal disturbances, which all 
began around the age of four or five. The subject experienced extreme auditory and visual 
hallucinations throughout her entire life as well as being diagnosed with irritable bowel 
syndrome. Her parents never sought medical treatment or medication for her symptoms but she 
did participate in some religious counseling. By the time she entered college and after other 
unsuccessful dietary elimination trials, she decided to independently eliminate gluten from her 
diet. This resulted in complete resolution of her symptoms. Hallucinations would return within 
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hours of any slight accidental gluten exposure and last 24-72hrs, giving her a clear indication of 
a definitive correlation between gluten ingestion and her neurologic symptoms. Strengths of this 
article included the fact that symptoms completely resolved after gluten elimination without any 
other intervention, providing a clear correlation. Also this subject was not diagnosed with autistic 
disorder or any other learning disability and was able to give an accurate description and detail of 
her symptoms. Limitations included the fact that there wasn’t any concrete laboratory data 
utilized as subject refused, given that her symptoms completely resolved and she didn’t find it 
necessary. It was not mentioned whether physician monitoring was present. 
 Herbert & Buckley (2013) described a young girl, now aged 13, who had been 
developing typically up until the age of four when she went into her pediatrician’s office for a 
well-child checkup. The article states that after that visit the girl unfortunately experienced 
severe, regressive autism and reverted back to an 18-month level of language and development. 
Her parents had attempted various treatment options with very limited success before starting her 
on a GFCF diet. After diet implementation she had showed a significant improvement in autistic 
behaviors. Over a period of several years her Childhood Autism Rating Score (CARS) decreased 
from an initial score of 49, representing severe autism, down to a score of 17, which represents 
non-autistic behaviors. During puberty the girl also began to experience seizure activity, which 
her parents negated with a GFCF ketogenic diet. Both dietary interventions provide evidence and 
hope that there is a possible correlation between diet and neurologic symptoms. Strengths of this 
article included the fact that symptoms and interventions are detailed chronologically providing a 
clear understanding of the sequence of events. Also an EEG was performed pre and post 
ketogenic dietary intervention to show concrete evidence of diminished seizure activity with no 
other changes in treatment plan. Limitations included the fact that the cause of significant 
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regression into autism in a previously neurotypical 4-year-old is not mentioned. Also, other 
biomedical treatments and supplements were being utilized and changed throughout her years of 
treatment. Lastly, the source of information was not mentioned. 
 Genius and Bouchard (2010) provided a description of a 5-year-old boy who was 
diagnosed with severe autism at the age of three, who also experienced multiple abnormal GI 
symptoms. Through laboratory testing the child was eventually diagnosed with Celiac Disease. A 
gluten-free diet was implemented along with dietary and supplemental measures. After just 3 
short months, the child could be mainstreamed back into a regular education classroom without 
any individualized special education plan and his autism symptoms completely disappeared. 
Strengths of this article included the fact that concrete laboratory data was utilized to make a 
formal diagnosis of Celiac Disease. Limitations would be that follow up biochemical nutritional 
testing was declined by his parents due to a complete resolution of symptoms and the source of 
information is unknown. 
 Two cohort studies were reviewed (Pennesi & Klein, 2012; Cade, Privette, Fregly, 
Rowland, Sun, Zele, Wagemaker, & Edelstein, 2000) which also showed improvements in 
autistic behavior and laboratory values after implementation of a GFCF diet. 
 Pennesi & Klein (2012) conducted a survey for the parents of 387 children diagnosed 
with an ASD who were already following a GFCF diet to some degree. The study aimed to 
evaluate whether the implementation of a GFCF diet resulted in improvements in autistic 
behaviors, social behaviors, and GI symptoms. A 90 item online questionnaire was administered 
to each of the 387 parent participants. Diet implementation, compliance, and length of 
implementation were measured. Also included were parental reports of observable changes in 
their child’s behaviors as well as GI symptoms.  Results show that implementing a GFCF diet 
AUTISM AND DIET   
 
15 
may positively impact autistic behaviors and GI symptoms, specifically for those with previous 
GI symptoms and food allergies reported (p<0.05). Strict adherence seems to have a better 
outcome than those who have dietary errors even just on occasion. Strengths of this study 
included the fact that explanation of the purpose was clear, there was a large sample size, and 
participants were grouped by specific diagnosis as well as diet adherence. Limitations included 
the fact that there weren’t any exclusion criteria for participants and there weren’t any control 
methods regarding diet implementation. Also the survey was subjective and responses could vary 
a great deal with each participant. 
 Cade et al (2000) also conducted a cohort study to determine whether the consumption of 
gluten and casein results in an abnormally high level of peptides in the urine and blood of 
schizophrenic adults and autistic children. The subjects included 83 schizophrenic men (age 17-
49), 37 schizophrenic women (ages 18-46), 128 autistic boys (ages 3.5-16), and 22 autistic girls 
(ages 3.5-14). Participants met DSM III criteria for his or her diagnosis. Laboratory data was 
collected from each subject and the same data was collected on control subjects who met similar 
age and sex characteristics. Data was collected on all subjects pre-intervention, at one month and 
three months after dietary intervention. Findings showed that 81% of the autistic children 
showed improvements in laboratory findings after three months of dietary intervention. Nineteen 
percent showed findings consistent with dietary error and continued gluten and casein 
consumption. Improvement was also noted after three months in the following behaviors: social 
isolation, eye contact, mutism, learning skills, hyperactivity, stereotypical activity, hygiene, 
panic attacks, and self mutilation. Strengths included the use of concrete laboratory findings and 
large sample sizes. Limitations were the short duration of dietary intervention and the fact that 
there wasn’t a control group consisting of individuals who also carried a similar diagnosis. 
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 Seung, Rogalski, Shankar, & Elder (2007) conducted a randomized, double blind 
crossover study to examine the effectiveness of a GFCF diet in children with ASDs in relation to 
verbal and nonverbal communication. Thirteen children (10 male and three female) between the 
ages two and 16 who had been diagnosed with autism participated. Diagnosis was based on the 
DSM-IV criteria for ASD. Videos of parent-child play interactions were used. Verbal exchanges 
were measured using the Systematic Analysis of Language Transcripts (SALT) and 
communication behaviors were analyzed using nonparametric (Friedman) tests. Results were as 
follows: Verbal social exchanges had means to include a baseline=16, GFCF=11, and regular 
diet=15; verbal imitations had means to include a baseline=3.85, GFCF=1.85, and regular 
diet=3.54; number of words produced had means to include a baseline=35, GFCF=32, and 
regular diet=37; and total utterances had means to include a baseline=42, GFCF=36, and regular 
diet=45. Strengths of the study included the fact that it is a double blind randomized clinical trial 
and food was prepared by one certified nutritionist for all participants. Limitations included a 
short intervention period, small sample size, and there was a large variance between baseline 
verbal abilities. Also this was a secondary analysis using existing data. 
 Knivsberg, Reichelt, Hoien, & Nodland (2002) conducted a single blind, randomized 
study to determine whether a GFCF diet may aid in enhanced learning for children diagnosed 
with autistic syndromes. They examined social, emotional, attention, communication, cognitive, 
sensory, and motor skills using standardized testing before and one year after diet 
implementation. A control group was utilized. Subjects included 20 children with autistic 
syndromes as well as abnormal urinary peptide patterns. Ages ranged from 59-127 months. Ten 
children were placed in the control group and 10 children utilized dietary intervention. The 
DIPAB (a Danish instrument for measuring autistic traits) was utilized to evaluate autistic 
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behavior, function of language, motor skills, communication, and social contact. Cognitive skills 
were measured using the Leiter International Performance Scale. Linguistic abilities were 
measured using the Illinois Test of Psycholinguistic Abilities and the Reynell Developmental 
Language Scale. Lastly, motor function was measured using the Movement Assessment Battery 
for Children. Many specific traits were examined based on the general behaviors of autism listed 
and every single trait showed marked improvement in the diet group when compared to the 
control group after one year of implementation. Strengths included a randomized, single blind 
study with a long implementation period. Inclusion criteria were utilized and educators were 
made available to parents throughout the study. Limitations on this study were that the sample 
size utilized was fairly small and it’s possible the study could have been double blinded. 
 Whiteley et al (2010) conducted a two stage, 24 month, scanbrit randomized, controlled, 
single-blind study of a GFCF dietary intervention for children with autism spectrum disorders to 
evaluate and compare the effects of dietary interventions between a control and intervention 
group using a comprehensive assessment battery in children diagnosed with ASDs. The 
participants included 55 children with an ASD diagnosis. There were 26 children in the 
intervention group and 29 in the control group.  Exclusion criteria for the study included any co-
morbid diagnoses of epilepsy, fragile-X syndrome, tuberous sclerosis, developmental age below 
24 months, or the use of pharmacologic therapy. Autism behaviors were assessed using the 
Autism Diagnostic Observation Schedule (ADOS) and Gilliam Autism Rating Scale (GARS). 
Developmental level was assessed using Vineland Adaptive Behavior Scale (VABS). Study 
members were blinded, but the parents were not blinded. Reassessments were performed at 8 and 
12 months. The control group was then also placed on a GFCF diet from 12-24 months and 
reassessed. Improvement was seen after 12 months in core autistic behaviors for the intervention 
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group with ADOS P=0.0022, GARS P=0.0001, as well as improvements in inattention and 
hyperactivity. There was a plateau effect thereafter. Strengths of this study included the fact that 
exclusion criteria were utilized, the study took place over a sufficient amount of time to truly see 
changes, and study participants were blinded. Limitations included the fact that the study was not 
double blinded, children continued to receive alternative therapies, and the study was unable to 
identify potential best responders based on their history or characteristics. 
 Elder, Shankar, Shuster, Theriaque, Burns, & Sherrill (2006) conducted a randomized, 
double-blind repeated measures crossover design pilot study to determine the effects of a GFCF 
diet on the behaviors of autistic children and evaluate the effects of dietary intervention on 
urinary peptide levels. 15 children (12 boys and 3 girls), ages 2-16 with ASD were included in 
the study. Tools used to measure subject qualities included the Autism Diagnostic Interview-
Revised (ADI-R), the Childhood Autism Rating Scale (CARS), Urinary Peptide Levels (UPL), 
and the Ecologic Communication Orientation (ECO) Language Sampling Summary. Data was 
collected prior to intervention, at week 6, and at week 12. Unfortunately, no significant changes 
were noted over the 12-week trial period. CARS p= .85, ECOS p= .29, behavioral frequencies 
.32 < p < .45, urinary peptide levels of gluten p= .44 and casein p= .11. Strengths included the 
fact that this was a randomized, double blind study and a placebo diet was used to keep parents 
blinded. Limitations included the small sample size used, the short duration of only 12 weeks, 
and the fact that dietary intervention was not performed in a controlled environment. 
 More recently, in 2015, two randomized double blind placebo controlled studies were 
performed although both studies lasted only a short period of time and did not produce positive 
results. One of the studies lasted only 7 days, which seems fairly pointless to even conduct, and 
the second lasted 12 weeks. The results are as follows. 
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 The first study was conducted by Pusponegoro, Ismael, Firmansyah, Sastroasmoro, & 
Vandenplas (2015) to determine the effect of gluten and casein supplementation in children, who 
were previously GFCF, on maladaptive behavior, gastrointestinal symptom severity, and urinary 
I-FABP (intestinal fatty acid binding protein) excretion which is a marker for intestinal mucosal 
cell damage. Fifty children, ages 4.3-6.7 with ASD, who had severe maladaptive behavior and a 
urinary I-FABP value of  > 96.97pg/mg creatinine, were included in the study. The Approach 
Withdraw Problems Composite (AWPC) was used to measure maladaptive behaviors pre and 
post gluten and casein exposure, the Gastrointestinal Symptom Severity Index (GSSI) was used 
to measure GI symptoms pre and post exposure, and Urinary I-FABP was measured pre and post 
exposure. The AWPC t-score decreased after supplementation in the placebo (p < 0.001) and 
intervention groups (p < 0.001). P=0.971 between the two groups. Both groups started with a 
GSSI of zero. After intervention, the median GSSI for the control group was 0 and median for 
the intervention group was 3. There was an increasing trend of I-FABP in the intervention group 
and a decreasing trend in the control group, yet changes between the two groups were not 
significantly different with p=0.416. The only strength noted for this study is that it was a 
randomized double-blind study. A fair number of limitations were noted that included a small 
sample size, short duration of gluten/casein consumption, the biscuits utilized as gluten/casein 
supplementation were probably not identical in taste, the chosen amount supplemented was 
arbitrary, the time between inclusion in study and introduction of dietary intervention varied, and 
outside therapies differed and were not considered for each child. 
 The second recent study was conducted by Hyman et al (2015) to obtain information on 
the safety and efficacy of the GFCF diet in children with autism. This was a 12-week double 
blind, placebo-controlled challenge study that included 14 children who were under the age of 
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six and diagnosed with Autistic Disorder, Asperger’s Disorder, or Pervasive Developmental 
Disorder Not Otherwise Specified based on the criteria from the DSM-IV. Participants were 
required to be enrolled in a comprehensive Applied Behavior Analysis Intervention program for 
the duration of the study. Multiple scales and scoring methods were utilized to include: Autism 
Diagnostic Interview (ADI-R), Autism Diagnostic Observation Schedule (ADOS), Mullen 
Scales of Early Learning, Vineland Adaptive Behavior Scales, World Health Organization 
growth standards, laboratory testing for food allergies and vitamin deficiencies, the Bristol Stool 
Scale, the Conners Abbreviated Rating Scale, and the Ritvo-Freeman Real Life Rating Scales. 
Unfortunately, no significant findings were noted on active challenge days when compared to 
placebo challenge days. There are some notable strengths and weaknesses of this study. 
Strengths included the utilization of Registered Dieticians to monitor adherence to diet and 
nutritional intake, the fact that consumption of gluten and casein was carefully measured, there 
was consistency in all the children receiving Applied Behavior Analysis (ABA) therapy, and 
everyone was blinded to the challenges given. Limitations included the small sample size, the 
fact that only a 4-6 week complete GFCF diet was required prior to the challenges which may be 
too short to see initial changes, and the fact that administering gluten and/or casein challenges 
would seem to defeat the purpose of long term GFCF dietary intervention. 
 Harris & Card (2012) conducted a cross-sectional pilot study to evaluate the nutritional 
influences on GI symptoms and behavior patterns in children with ASD. Participants included 13 
children, aged 5-12 years old diagnosed with an ASD, who were recruited from the Asperger’s 
Support Network website. An online survey was conducted which included questions regarding 
general health, demographics, GI symptoms, behavior patterns, and a Food Frequency 
Questionnaire (FFQ). Gastrointestinal Symptoms Rating Scale (GSRS) was used to rate 
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abnormal GI symptoms, and the Childhood Autism Rating Scale (CARS) was used to rate 
behavior patterns. More than half of the children were already on a GFCF diet by parental 
choice. 53.8% of the children did experience postprandial GI symptoms according to the survey. 
Mean GSRS score was 19.2 and mean CARS score was 43.9 and unfortunately scores did not 
differ according to diet. However, 100% of the parents with children on a GFCF diet (n=7) 
reported improved GI and behavior patterns after diet implementation. A couple strengths for 
this study included the use of validated questionnaires and relative homogeneity of the sample. 
Limitations included the small sample size, the fact that the questionnaires were subjective, the 
uncertain ability of parents to quantify the severity of their child’s symptoms, and the differences 
in parental implementation of the GFCF diet.  
 A more unique approach to studying dietary effects on children with ASD was conducted 
by de Magistris et al (2013) to challenge the hypothesis that dietary-derived non-self antigens 
could permeate impaired gut barrier and stimulate the immune system, affecting or increasing 
autism symptoms. Participants included 31 children with an ASD diagnosis currently following a 
GFCF diet for an average of 3 years, 131 children with an ASD diagnosis following a regular 
diet, and 44 healthy children utilized as matched controls. Data collected included intestinal 
permeability measurements and antibodies to food antigens. A statistical analysis was performed 
using the Mann-Whitney, the Kruskal-Wallis and Dunn’s, and Fisher exact tests. Approximately 
twenty five percent of the enrolled ASD children had impaired intestinal barrier function. The 
GFCF diet appeared to normalize intestinal barrier impairment. Immune response was noted to 
be triggered by gluten and casein consumption in some ASD children. It is probable that 
determination of antibody titers to food antigens could be used to identify potential responders to 
the GFCF diet according to the study. Strengths of this study included the large sample size of 
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ASD children, the fact that control groups were present, and concrete laboratory evidence was 
utilized. Limitations included a smaller control group when compared to the study group, the fact 
that dietary intervention was not professionally monitored, and autism behavior symptoms 
specifically were not evaluated. 
 One last and the most recent case-control study that was examined was conducted by 
Mari-Bauset, Llopis-Gonzalez, Zazpe, Mari-Sanchis & Suarez-Varela (2016) to determine 
whether children with ASD on a GFCF diet vs. a regular diet have lower anthropometric 
measures, varied nutrient intake, and are less likely to meet daily-recommended intake values. 
Children ages 6-9 years old diagnosed with an ASD were enrolled in the study and the severity 
of autism symptoms was not considered (n=105). The study group consisted of 20 children and 
the control group consisted of 85 children. Height and weight measurements were utilized to 
calculate BMI. Caloric intake, macronutrients, and micronutrients were compared between the 
two groups. The Healthy Eating Index was utilized also to compare nutrients and Dietary 
Reference Intakes were utilized to measure adequate or inadequate intake. Overall, ASD children 
on a GFCF diet had lower BMI’s than those on a regular diet. Vitamin and nutrient differences 
were noted between the two diets with the GFCF group being deficient in some nutrients but the 
regular diet group experienced deficiencies in other nutrients. Typically the GFCF diet group ate 
a “healthier” diet than their counterparts. Strengths included the children presented with similar 
characteristics in socioeconomic status, place of residence, ethnicity, and living conditions and 
the children were studied in parallel over the same time period. Limitations included a small 
sample size, the fact that only a 3-day food record was utilized, the GFCF diet was not monitored 
professionally, and autism behaviors or characteristics were not mentioned in this study. 
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 Articles were reviewed and graded using the American Association of Critical-Care 
Nurses’ (AACN) updated evidence-leveling system, which was revised in 2008. This upgraded 
system helps to alleviate confusion when compared to other grading systems, as the order of 
grading had originally been reversed compared to others. “Research designs identified in the new 
leveling system include meta-analysis, meta-synthesis (the qualitative counterpart to meta-
analysis), randomized and nonrandomized studies, qualitative research, descriptive or 
correlational studies, systematic reviews, and integrative reviews” (Armola et al, 2009). 
 This grading system uses an alphabetical instead of numerical scale to further minimize 
confusion when compared with other systems. Letters range from A to M: A being the highest 
level of evidence to include meta-analyses and meta-syntheses with consistent results, and M 
referring to manufacturer’s recommendations only (Armola et al, 2009). This grading system 
was chosen due to the broad range of description for hierarchy and the variability of the 15 
studies examined. A synopsis of each study with its individual level of hierarchy grade can be 
found in the Appendix. 
Discussion 
Dissemination 
 Background information and theory as well as a summary of findings via poster was 
presented to a local pediatrician’s office to encourage practicing physicians to include dietary 
recommendations in the care and treatment of children with an ASD. The poster was utilized 
since it was unlikely that the small family practice had the resources or space available to 
conduct a PowerPoint presentation. Time was allotted for discussion at the end of the 
presentation to answer questions and obtain opinions and feedback from the physicians and 
office staff. Finally, an anonymous survey was conducted to determine whether the physicians 
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and staff found the information useful and to determine whether they saw it plausible to include 
dietary recommendations in their treatment plans proceeding forward. 
 Three physicians, one physician’s assistant, and two registered nurses were present for 
the presentation. Overall, the staff was not aware of dietary intervention for children with an 
ASD other than in cases where a true dietary allergy was present. The physicians and physician’s 
assistant were skeptical to agree upon immediately recommending a GFCF diet to their patients. 
They did agree, however, to perform some more research independently in order to gain a 
broader understanding of dietary implications in children with an ASD. All agreed that they 
might possibly begin making the recommendation to parents in the future, so long as the parent 
understands that positive results are not guaranteed. 
Interpretation 
 Eleven out of the 15 studies did show improvements in the symptoms being measured 
after eliminating gluten and casein from the subjects’ diet (Hsu et al, 2009; Pennesi & Klein, 
2012; Knivsberg et al, 2002; Whiteley et al, 2010; Cade et al, 2000; Harris & Card, 2012; de 
Magistris et al, 2013; Mari-Bauset et al, 2016; Genius & Lobo, 2014; Herbert & Buckley, 2013; 
Genius & Bouchard, 2010). The four studies that showed no significant improvement (Seung et 
al, 2007; Elder et al, 2006; Pusponegoro et al, 2015; Hyman et al, 2015) in any measured 
symptoms had small sample sizes, short durations of diet implementation, or dietary infractions 
as part of the study. Overall, better results had been reported after completing one full year of 
dietary intervention in the studies lasting that length of time (Cade et al, 2000; Hsu et al, 2009; 
Knivsberg et al, 2002; Whiteley et al, 2010; de Magistris et al, 2013; Genius & Lobo, 2014; 
Herbert & Buckley, 2013).  
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 Many of these studies seem flawed in one way or another. A common theme among all of 
the studies is the difficulty in knowing whether strict adherence to the GFCF diet was successful 
without mistake, since all of the studies allowed the children to remain in their own home and 
continue with life as usual otherwise.  
 It would make sense that long term dietary change would need to take place in order to 
see major changes in neurologic or behavioral symptoms. Just as any other part of the human 
body, if damage has occurred to the GI tract due to the consumption of gluten or casein, it would 
only seem reasonable that healing of the GI tract would take time after complete removal of 
these proteins from the child’s diet has been successfully accomplished. 
Implications for Nursing 
 Although the body of evidence for this literature review is not 100% consistent, it is not 
without merit that the dietary intervention of removing gluten and casein from the autistic child’s 
diet has the possibility of proving to be beneficial. Like any and every therapy or treatment for 
ASD’s, a child may or may not respond positively to dietary intervention as children respond 
differently to every treatment option currently available (Whiteley et al, 2013). It is important for 
parents and physicians of children with autism to be aware of this possibility of gastrointestinal 
inflammation and central nervous system correlation. The hope is that increased awareness will 
lead to increased practice recommendations for dietary changes from practicing pediatricians to 
the parents of children affected by ASD. 
 Based on the findings of this review, the first desired practice recommendation to be 
made would be to disseminate findings and educate local developmental pediatric practices and 
county developmental agencies of the possible benefits of following a GFCF diet as well as the 
possible negative impact of gluten and/or casein consumption in autistic children. “Clinicians 
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working with families of individuals with ASD are often asked for advice and find themselves 
unable to offer the most up-to-date and scientifically credible information” (Elder, 2008, p.583). 
The fact that there is even some hope and proof that a simple dietary change could alleviate 
symptoms related to autism should be known by the clinicians that see and treat these children on 
a daily basis. 
 The American Family Physician (AFP) Strength of Recommendation Taxonomy (SORT) 
was utilized to review this recommendation. According to this system, “grades are assigned on 
the basis of quality and consistency of available evidence” (Ebell et al, 2004). This scale is 
intended to allow its use among various sources of evidence and is currently used by several 
medical journals. Recommendations are given a grade A, B, or C. The above recommendation is 
given a grade B for overall strength since results are inconsistent and studies are limited. 
 The second recommendation proposed would be to encourage these developmental 
pediatricians and local developmental agencies to include dietary change as a possible treatment 
option for children diagnosed with an ASD. Treatment recommendations generally include 
educational intervention, physical and developmental therapy, and behavioral treatment (Elder, 
2008). Yet “there is increasing recognition that the expression of ASD in some sub-groups may 
also include a number of additional elements beyond psychiatry that may be potentially relevant” 
(Whiteley et al, 2010, p.88). Diet changes are under scrutiny as a physical trigger for 
psychological symptoms. The hypothesis that eliminating gluten and casein consumption proves 
beneficial in some way has been strengthened by the results of 11 of the 15 studies examined. It 
would only seem fair to offer desperate parents seeking answers any and every angle of 
treatment that is available to possibly benefit their children.  
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 This practice recommendation is also given the strength of recommendation grade B 
using the SORT hierarchy due to the inconsistency of results and limited availability of evidence. 
It is important to note however, that every single autistic child is unique and no two are exactly 
alike. The diagnosis is termed autism spectrum disorder because there is an extremely large 
“spectrum” of symptoms that may be seen from child to child (Pennesi & Klein, 2012). 
Therefore, it is impossible to determine that any treatment option, including diet, will 100% be 
effective for all children diagnosed. 
 Implications for implementing the two proposed practice recommendations would be 
finding the time and appropriate resources and personnel to travel to local physician offices and 
developmental agencies. Also the reluctance of clinicians toward adopting new practice or 
recommendations could prove to be a barrier toward successful implementation. It would prove 
beneficial and probably more convincing for clinicians, if further research including larger 
sample sizes and longer duration paired with better control over interventions was conducted. 
 It is my hope that upon completion of my Master’s in Nursing Education degree, I will be 
able to work directly with physicians who treat children with autism as well as educate the 
parents and families who are caring for these children. I hope to bring an increased awareness of 
alternative treatment options, including the GFCF diet, as well as conventional treatment options 
to the parents of children with autism. 
Conclusion 
 Although the topic of dietary intervention for children with ASD seems to be growing, 
scientific information and evidence is still extremely limited. Studies vary in their methods, 
measurements, and results. Recommendations for future studies would include adequate control 
groups which mimic the intervention group, larger sample sizes overall, longer durations of 
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complete gluten and casein removal from the diet, and more concrete symptom measurement and 
evaluation versus parental input.  
 It is interesting and reassuring to know that there are new and alternative treatments being 
addressed for the growing number of autistic children present in our country today. Many parents 
are unsatisfied with current diagnosis standards and traditional treatment options (White, 2003). 
This may lead some to turn to many of the alternative treatments that are currently floating 
around without full knowledge of whether or not they will work. Yet although current literature 
is not fully supportive of the dietary removal of gluten and dairy as a guaranteed cure, current 
results may leave parents, physicians, and therapists hopeful and lean toward a probable benefit 
for many children. 
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Authors 
(Year) 
Title 
Publication 
Purpose Design Sample Data Collection 
and 
Measurement 
Findings Strengths and 
Limitations 
Level of 
Evidence 
Pennesi, C.M. 
& Klein, L.C. 
(2012). 
 
Effectiveness 
of the gluten-
free, casein-
free diet for 
children 
diagnosed 
with autism 
spectrum 
disorder: 
based on 
parental 
report. 
 
Nutritional 
Neuroscience 
15(2), 85-91 
To evaluate 
whether the 
implementation 
of a gluten and 
casein free diet 
results in 
improvement in 
autistic 
behaviors, social 
behaviors, and 
GI symptoms in 
children with an 
autism spectrum 
disorder (ASD) 
diagnosis. 
Longitudinal 
Survey 
Cohort Study 
N=387 
participants 
who were 
parents or 
primary 
caregivers 
of children 
with a 
clinical 
diagnosis of 
ASD. No 
exclusion 
criteria were 
identified. 
A 90 item online 
questionnaire 
was administered 
to each 
participant. Diet 
implementation, 
compliance, and 
length of 
implementation 
was measured. 
Also included 
were parental 
reports of 
observable 
changes in their 
child’s behaviors 
as well as 
gastrointestinal 
symptoms.   
Results show 
that 
implementing 
a gluten and 
casein free 
diet may 
positively 
impact autistic 
behaviors and 
GI symptoms, 
specifically 
for those with 
previous GI 
symptoms and 
food allergies 
reported 
(p<0.05). 
Strict 
adherence 
seems to have 
a better 
outcome than 
those who 
have dietary 
errors even 
just on 
occasion. 
Strengths: 
*Explanation of 
the purpose was 
clear. 
*Large sample 
size. 
*Participants 
were grouped by 
specific 
diagnosis as well 
as diet 
adherence. 
 
Limitations: 
*No exclusion 
criteria for 
participants. 
*Subjective 
survey could 
vary with each 
participant. 
*No control or 
methods 
regarding diet 
implementation. 
AACN level 
of evidence: 
Grade C 
(Cohort 
Study with 
inconsistent 
results). 
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Authors 
(Year) 
Title 
Publication 
Purpose Design Sample Data Collection 
and 
Measurement 
Findings Strengths and 
Limitations 
Level of 
Evidence 
Hsu, C.L., 
Lin, D.C.Y., 
Chen, C.L., 
Wang, C.M., 
& Wong, 
A.M.K. 
(2009). 
 
The effects 
of a gluten 
and casein-
free diet in 
children 
with autism: 
a case 
report. 
 
Chang Gung 
Med J 32, 
459-465. 
To provide a 
detailed report 
of one child 
who showed 
significant 
improvements 
in autistic 
behaviors after 
implementing a 
gluten and 
casein-free 
diet. 
Observational 
case-report 
One child age 
42 months at 
the initiation of 
the study, 
diagnosed with 
autism, growth 
and 
developmental 
retardation, and 
CHARGE 
syndrome. 
Data was 
collected at 2.5 
months, 5 
months, and 11 
months after 
initiation of diet 
implementation. 
The Chinese 
Child 
Developmental 
Inventory as well 
as the Bayley 
Scales of Infant 
Development 
were used to 
classify 
developmental 
ages in eight 
different areas of 
growth and 
development. 
Improvement 
in all areas of 
development 
were noted at 
the 11 month 
mark of follow 
up as well as 
weight 
percentiles 
which were 
originally 
below the third 
percentile and 
had increased 
to 
approximately 
the 15th 
percentile. 
Strengths: 
*Objective 
developmental 
measurement 
tools were 
utilized before 
and after 
interventions. 
*Intermittent 
follow up 
periods. 
*Long follow 
up. 
Limitations: 
*Single observed 
case report. 
*Double blind 
observations 
before and after 
initiation of diet 
were not 
performed. 
*Child continued 
to receive 
physical, 
occupational, 
speech, and 
sensory 
integration 
therapies. 
AACN level 
of evidence: 
Grade E 
(single case 
report and 
no blindness 
used for 
evaluations). 
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Authors 
(Year) 
Title 
Publication 
Purpose Design Sample Data 
Collection and 
Measurement 
Findings Strengths 
and 
Limitations 
Level of 
Evidence 
Seung, H., 
Rogalski, Y., 
Shankar, M., 
& Elder, J. 
(2007). 
 
The gluten- 
and casein-free 
diet and 
autism: 
communicatio
n outcomes 
from a 
preliminary 
double-blind 
clinical trial. 
 
Journal of 
Medical 
Speech-
Language 
Pathology 
15(4), 337-
345. 
To examine the 
effectiveness of 
a gluten and 
casein free diet 
in children with 
autism 
spectrum 
disorders in 
relation to 
verbal and 
nonverbal 
communication
. 
Randomized, 
double-blind 
crossover 
design study. 
Thirteen 
children (10 
male and three 
female) 
between the 
ages two and 
16 who had 
been 
diagnosed 
with autism 
participated. 
Diagnosis was 
based on the 
DSM-IV 
criteria for 
autism 
spectrum 
disorder. 
Videos of 
parent-child 
play 
interactions 
were used. 
Verbal 
exchanges were 
measured using 
the Systematic 
Analysis of 
Language 
Transcripts 
(SALT). 
Communicatio
n behaviors 
were analyzed 
using 
nonparametric 
(Friedman) 
tests. 
Verbal social 
exchanges: 
Mean- 
baseline=16, 
GFCF=11, 
regular 
diet=15. 
Verbal 
imitations: 
Mean- 
baseline=3.85
, GFCF=1.85, 
regular 
diet=3.54. 
Number 
words 
produced: 
Mean- 
baseline=35, 
GFCF=32, 
regular 
diet=37. Total 
utterances: 
Mean- 
baseline=42, 
GFCF=36, 
regular 
diet=45. 
Strengths: 
*Randomized 
clinical trial. 
*Double-
blind. 
*Food was 
prepared by 
one certified 
nutritionist 
for all 
participants. 
 
Limitations: 
*Short 
intervention 
period. 
*Small sample 
size. 
*Large 
variance 
between 
baseline verbal 
abilities. 
*A secondary 
analysis using 
existing data. 
*No control 
group used.  
 
 
 
AACN 
Level of 
Evidence: 
Grade B 
(randomize-
ed double-
blind study 
with 
consistent 
results). 
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Authors 
(Year) 
Title 
Publication 
Purpose Design Sample Data 
Collection and 
Measurement 
Findings Strengths 
and 
Limitations 
Level of 
Evidence 
Knivsberg, 
K.M., 
Reichelt, K.L., 
Hoien, T., & 
Nodland, M. 
(2002). 
 
A randomized, 
controlled 
study of 
dietary 
intervention in 
autistic 
syndromes. 
 
Nutritional 
Neuroscience 
5(4), 251-261. 
To determine 
whether a 
gluten and 
casein free diet 
may aid in 
enhanced 
learning for 
children 
diagnosed with 
autistic 
syndromes. 
Single blind, 
randomized 
study 
examined 
social, 
emotional, 
attention, 
communicatio
n, cognitive, 
sensory, and 
motor skills 
using 
standardized 
testing before 
and one year 
after diet 
implementatio
n. Control 
group was 
utilized. 
20 children 
with autistic 
syndromes as 
well as 
abnormal 
urinary 
peptide 
patterns. Ages 
ranged from 
59-127 
months. 10 
children were 
placed in the 
control group 
and 10 
children 
utilized dietary 
intervention. 
DIPAB 
(standardized 
Danish scheme) 
utilized to 
evaluate autistic 
behavior, 
function of 
language, motor 
skills, 
communication, 
and social 
contact. 
Cognitive skills 
measured using 
the Leiter 
International 
Performance 
Scale. Linguistic 
abilities 
measured using 
the Illinois Test 
of 
Psycholinguistic 
Abilities and 
Reynells 
spraktest. Motor 
function 
measured using 
Movement 
Assessment 
Battery for 
Children. 
Many specific 
traits were 
examined 
based on the 
general 
behaviors of 
autism listed. 
Every single 
trait showed 
marked 
improvement 
in the diet 
group when 
compared to 
the control 
group after 
one year.  
Strengths: 
*Long 
implementati-
on period.  
*Randomized
, single blind 
study. 
*Inclusion 
criteria 
utilized. 
*Educators 
were 
available to 
parents 
throughout 
the study. 
 
Limitations: 
*Study could 
have been 
double 
blinded. 
*Small 
sample size. 
 
AACN 
Level of 
Evidence: 
Grade B 
(randomiz-
ed blinded 
study with 
consistent 
results). 
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Author 
(Year) 
Title 
Publication 
Purpose Design Sample Data 
Collection and 
Measurement 
Findings Strengths 
and 
Limitations 
Level of 
Evidence 
Whiteley, P., 
Haracopos, D., 
Knivsberg, A., 
Reichelt, K. 
L., Parlar, S., 
Jacobsen, J., 
Seim, A., 
Pedersen, L., 
Schondel, M., 
& Shattock, P. 
(2010). 
 
The scanbrit 
randomized, 
controlled, 
single-blind 
study of a 
gluten- and 
casein-free 
dietary 
intervention 
for children 
with autism 
spectrum 
disorders. 
 
Nutritional 
Neuroscience 
13(2), 87-100. 
To evaluate and 
compare the 
effects of 
dietary 
intervention 
between a 
control and 
intervention 
group using a 
comprehensive 
assessment 
battery in 
children 
diagnosed with 
autism 
spectrum 
disorders. 
A randomized, 
controlled, 
single-blind, 2-
stage/24 month 
study using the 
gluten and 
casein free 
diet. 
Children with 
autism 
spectrum 
disorder 
diagnosis. 
N=26 in the 
intervention 
group and 
N=29 in the 
control group.  
Exclusion 
criteria: co-
morbid 
diagnoses of 
epilepsy, 
fragile-X 
syndrome, 
tuberous 
sclerosis, 
developmental 
age below 24 
months, 
pharmacologic 
therapy.  
Autism 
behaviors 
assessed using 
Autism 
Diagnostic 
Observation 
Schedule 
(ADOS) and 
Gilliam Autism 
Rating Scale 
(GARS). 
Developmental 
level assessed 
using Vineland 
Adaptive 
Behavior Scale 
(VABS). Study 
members 
blinded. 
Parents not 
blinded. 
Reassessments 
performed at 8 
and 12 months. 
Control group 
then placed on 
diet from 12-24 
months and 
reassessed. 
Improvement 
seen after 12 
months in 
core autistic 
behaviors for 
intervention 
group. ADOS 
P=0.0022, 
GARS 
P=0.0001, as 
well as 
improvements 
in inattention 
and 
hyperactivity. 
Plateau effect 
thereafter.  
Strengths: 
*Study 
participants 
blinded. 
*Sufficient 
length of 
time. 
*Exclusion 
criteria. 
 
Limitations: 
*Not double 
blinded. 
*Children 
continued to 
receive 
alternative 
therapies. 
*Study 
unable to 
identify 
potential best 
responders. 
AACN 
Level of 
Evidence: 
Grade B 
(randomiz-
ed, 
controlled 
study with 
consistent 
results). 
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Author 
(Year) 
Title 
Publication 
Purpose Design Sample Data 
Collection 
and 
Measurement 
Findings Strengths 
and 
Limitations 
Level of 
Evidence 
Cade, R., 
Privette, M., 
Fregly, M., 
Rowland, N., 
Sun, Z., Zele, 
V., 
Wagemaker, 
H., & 
Edelstein, C. 
(2000). 
 
Autism and 
schizophrenia: 
intestinal 
disorders. 
 
Nutritional 
Neuroscience 
3, 57-72. 
To determine 
whether the 
consumption 
of gluten and 
casein results 
in an 
abnormally 
high level of 
peptides in the 
urine and 
blood of 
schizophrenic 
adults and 
autistic 
children. 
Cohort study. N=83 
schizophrenic 
men (age 17-
49), N=37 
schizophrenic 
women (ages 
18-46), N=128 
autistic boys 
(ages 3.5-16), 
and N=22 
autistic girls 
(ages 3.5-14). 
Participants 
met DSM III 
criteria for his 
or her 
diagnosis. 
Laboratory 
tests were 
drawn from 
subjects as 
well as control 
subjects with 
similar age 
and sex pre-
intervention, 
at one month 
and three 
months after 
intervention. 
81% of the 
autistic children 
showed 
improvements 
in laboratory 
findings after 
three months of 
dietary 
intervention. 
19% showed 
findings 
consistent with 
dietary error 
and continued 
gluten and 
casein 
consumption. 
Improvement 
also noted after 
3 months in the 
following 
behaviors: 
social isolation, 
eye contact, 
mutism, 
learning skills, 
hyperactivity, 
stereotypical 
activity, 
hygiene, panic 
attacks, and self 
mutilation. 
Strengths: 
*Concrete 
laboratory 
findings. 
*Large sample 
sizes. 
 
Limitations:  
*Short 
duration. 
*No control 
group for 
diagnosed 
individuals. 
*No blinding. 
AACN Level 
of Evidence: 
Grade C 
(correlational 
cohort study 
with 
consistent 
results). 
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Author 
(Year) 
Title 
Publication 
Purpose Design Sample Data 
Collection 
and 
Measurement 
Findings Strengths 
and 
Limitations 
Level of 
Evidence 
Elder, J. H., 
Shankar, M., 
Shuster, J., 
Theriaque, D., 
Burns, S., & 
Sherrill, L. 
(2006). 
 
The gluten-
free, casein-
free diet in 
autism: results 
of a 
preliminary 
double blind 
clinical trial. 
 
Journal of 
Autism and 
Developmenta
l Disorders 
36(3), 413-
420. 
To determine 
the effects of a 
gluten-free, 
casein-free 
diet on the 
behaviors of 
autistic 
children and 
evaluate the 
effects of 
dietary 
intervention 
on urinary 
peptide levels. 
Randomized, 
double-blind 
repeated 
measures 
crossover 
design pilot 
study. 
15 children, 
ages 2-16 with 
autism 
spectrum 
disorder (12 
boys and 3 
girls). 
Tools used to 
measure 
subject 
qualities 
included: 
Autism 
Diagnostic 
Interview-
Revised (ADI-
R), Childhood 
Autism Rating 
Scale (CARS), 
Urinary 
Peptide Levels 
(UPL), and 
Ecologic 
Communicatio
n Orientation 
(ECO) 
Language 
Sampling 
Summary. 
Data was 
collected prior 
to 
intervention, 
at week 6, and 
at week 12. 
No significant 
changes in 
findings over 
12 week trial 
period. CARS 
p=.85, ECOS 
p=.29, 
behavioral 
frequencies 
.32<p<.45, 
urinary 
peptide levels 
of gluten 
p=.44 and 
casein p=.11. 
Strengths: 
*Randomized, 
double-blind 
study. 
*Placebo diet 
used to keep 
parents 
blinded. 
 
Limitations: 
*Small sample 
size. 
*Short 
duration. 
*Dietary 
intervention 
was not in a 
controlled 
environment. 
AACN Level 
of Evidence: 
Grade C 
(randomized 
controlled 
study with 
inconsistent 
results). 
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Author 
(Year) 
Title 
Publication 
Purpose Design Sample Data 
Collection 
and 
Measurement 
Findings Strengths 
and 
Limitations 
Level of 
Evidence 
Pusponegoro, 
H.D., Ismael, 
S., 
Firmansyah, 
A., 
Sastroasmoro, 
S., 
Vandenplas, 
Y. (2015). 
 
Gluten and 
casein 
supplementa-
tion does not 
increase 
symptoms in 
children with 
autism 
spectrum 
disorder. 
 
Acta 
Paediatrica, 
104, e500-
e505.  
To determine 
the effect of 
gluten and 
casein 
supplementa-
tion in 
children who 
were 
previously 
GFCF, on 
maladaptive 
behavior, 
gastrointes-
tinal symptom 
severity, and 
urinary I-
FABP 
excretion. 
Randomized, 
double-blind, 
placebo 
controlled 
trial. 
50 children, 
ages 4.3-6.7 
with ASD 
who had 
severe 
maladaptive 
behavior and a 
urinary I-
FABP value 
of  > 
96.97pg/mg 
creatinine. 
The AWPC 
(Approach 
Withdraw 
Problems 
Composite) 
was used to 
measure 
maladaptive 
behaviors pre 
and post 
gluten and 
casein 
exposure, the 
GSSI 
(Gastrointes-
tinal Symptom 
Severity 
Index) was 
used to 
measure GI 
symptoms pre 
and post 
exposure, and 
Urinary I-
FABP was 
measured pre 
and post 
exposure. 
AWPC t-score 
decreased after 
supplementation 
in placebo (p < 
0.001) and 
intervention 
groups (p < 
0.001). p=0.971 
between the two 
groups. Both 
groups started 
with a GSSI of 
zero. After 
intervention, the 
median GSSI for 
the control group 
was 0 and 
median for the 
intervention 
group was 3. 
There was an 
increasing trend 
of I-FABP in the 
intervention 
group and a 
decreasing trend 
in the control 
group, yet 
changes between 
the two groups 
were not 
significantly 
different with 
p=0.416. 
Strengths: 
*Randomized 
double-blind 
study. 
 
Limitations: 
*Small sample 
size. 
*Short duration 
of gluten/casein 
consumption. 
*Biscuits utilized 
as gluten/casein 
supplementa-tion 
were probably 
not identical in 
taste. 
*Chosen amount 
supplemented 
was arbitrary. 
*Time between 
inclusion in study 
and introduction 
of dietary 
intervention 
varied. 
*Outside 
therapies differed 
and were not 
considered for 
each child. 
AACN Level 
of Evidence: 
Grade C 
(randomized 
double-blind 
study with 
inconsistent 
results). 
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Author 
(Year) 
Title 
Publication 
Purpose Design Sample Data 
Collection 
and 
Measurement 
Findings Strengths 
and 
Limitations 
Level of 
Evidence 
Harris, C., 
Card, B. 
(2012).  
 
A pilot study 
to evaluate 
nutritional 
influences on 
gastrointes-
tinal 
symptoms and 
behavior 
patterns in 
children with 
Autism 
Spectrum 
Disorder. 
 
Complemen-
tary Therapies 
in Medicine, 
20, 437-440. 
To evaluate 
the 
relationship 
between GI 
symptoms and 
behavior 
patterns, and 
the influence 
of a GFCF 
diet on these 
issues in 
children 
diagnosed 
with ASD. 
Cross-
sectional 
study. 
13 children 
aged 5-12 
years old 
diagnosed 
with an ASD, 
who were 
recruited from 
the Asperger’s 
Support 
Network 
website. 
Online survey 
included 
questions 
regarding 
general health, 
demographics, 
GI symptoms, 
behavior 
patterns, and a 
Food 
Frequency 
Questionnaire 
(FFQ). 
Gastrointestin
al Symptoms 
Rating Scale 
(GSRS) was 
used to rate 
abnormal GI 
symptoms, 
and the 
Childhood 
Autism Rating 
Scale (CARS) 
was used to 
rate behavior 
patterns. 
More than ½ of 
the children 
were on a GFCF 
diet by parental 
choice. 53.8% of 
the children 
experienced post 
prandial GI 
symptoms. 
Mean GSRS 
score was 19.2 
and mean CARS 
score was 43.9. 
Scores did not 
differ according 
to diet. 
However, 100% 
of the parents 
with children on 
a GFCF diet 
(n=7) reported 
improved GI and 
behavior 
patterns after 
diet 
implementation. 
Strengths: 
*Use of 
validated 
questionn-
aires. 
*Relative 
homogeneity 
of the 
sample. 
 
Limitations: 
*Small 
sample size. 
*Subjective 
questionn-
aires. 
*Uncertain 
ability of 
parents to 
quantify the 
severity of 
their child’s 
symptoms. 
*Differences 
in parental 
implementa-
tion of GFCF 
diet.  
 
AACN Level 
of Evidence: 
Grade C 
(Cross-
sectional 
survey study 
with 
inconsistent 
results). 
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Author 
(Year) 
Title 
Publication 
Purpose Design Sample Data 
Collection 
and 
Measurement 
Findings Strengths and 
Limitations 
Level of 
Evidence 
Hyman, S.L., 
Stewart, P.A., 
Foley, J., 
Cain, U., 
Peck, R., 
Morris, D.D., 
Wang, H., & 
Smith, T. 
(2015). 
 
The gluten-
free/casein-
free diet: a 
double-blind 
challenge trial 
in children 
with autism. 
 
Journal of 
Autism and 
Developmen-
tal Disorders, 
46(1), 205-
220. 
To obtain 
information 
on the safety 
and efficacy 
of the gluten-
free/casein-
free diet in 
children with 
Autism. 
A 12-week 
double-blind, 
placebo-
controlled 
challenge 
study. 
14 children who 
were under the 
age of 6 and 
diagnosed with 
Autistic 
Disorder, 
Asperger’s 
Disorder, or 
Pervasive 
Developmen-tal 
Disorder Not 
Otherwise 
Specified based 
on the criteria 
from the 
Diagnostic and 
Statistical 
Manual of 
Mental Disorders 
4th Edition. 
Participants were 
required to be 
enrolled in a 
comprehensive 
Applied Behavior 
Analysis 
Intervention 
program for the 
duration of the 
study. 
Multiple scales 
and scoring 
methods were 
utilized to 
include: Autism 
Diagnostic 
Interview (ADI-
R), Autism 
Diagnostic 
Observation 
Schedule 
(ADOS), Mullen 
Scales of Early 
Learning, 
Vineland 
Adaptive 
Behavior Scales, 
World Health 
Organization 
growth standards, 
laboratory testing 
for food allergies 
and vitamin 
deficiencies, the 
Bristol Stool 
Scale, the 
Conners 
Abbreviated 
Rating Scale, and 
the Ritvo-
Freeman Real 
Life Rating 
Scales. 
No 
significant 
findings on 
active 
challenge 
days when 
compared to 
placebo 
challenge 
days. 
Strengths: 
*Utilized 
Registered 
Dieticians to 
monitor adherence 
to diet and 
nutritional intake. 
*Consumption of 
gluten/casein was 
carefully 
measured. 
*Children were 
receiving 
consistent ABA 
therapy. 
*Everyone was 
blinded to 
challenges given. 
 
Limitations: 
*Small sample 
size. 
*4-6 week 
complete GFCF 
diet prior to 
challenges may be 
too short to see 
initial changes. 
*Administering 
gluten and/or 
casein challenges 
defeats purpose of 
long term GFCF 
diet. 
AACN Level 
of Evidence: 
Grade C 
(Double-blind 
placebo-
controlled 
challenge 
study with 
inconsistent 
results). 
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Author 
(Year) 
Title 
Publication 
Purpose Design Sample Data 
Collection 
and 
Measurement 
Findings Strengths 
and 
Limitations 
Level of 
Evidence 
de Magistris, L., 
Picardi, A., 
Siniscalco, D., 
Riccio, M.P., 
Sapone, A., 
Cariello, R., 
Abbadessa, S., 
Medici, N., 
Lammers, K.M., 
Schiraldi, C., 
Iardino, P., 
Marotta, R., 
Tolone, C., 
Fasano, A., 
Pascotto, A., 
Bravaccio, C. 
(2013). 
 
Antibodies 
against food 
antigens in 
patients with 
autistic spectrum 
disorders. 
 
BioMed 
Research 
International, 1-
11. 
To challenge 
the hypothesis 
that dietary-
derived 
nonself 
antigens could 
permeate 
impaired gut 
barrier and 
stimulate the 
immune 
system, 
affecting or 
increasing 
autism 
symptoms. 
Evaluation of 
anti-body 
prevalence in 
study group, 
control group, 
and 
neurotypical 
group. 
31 children 
with an ASD 
diagnosis 
currently 
following a 
GFCF diet for 
an average of 
3 years, 131 
children with 
an ASD 
diagnosis 
following a 
regular diet, 
and 44 healthy 
children 
utilized as 
matched 
controls. 
Intestinal 
permeability 
measurements, 
antibodies to 
food antigens, 
statistical 
analysis using 
Mann-
Whitney,  
Kruskal-
Wallis and 
Dunn’s, and 
Fisher exact 
tests. 
25.6% of the 
enrolled ASD 
children had 
impaired 
intestinal 
barrier 
function. 
GFCF diet 
appears to 
normalize 
barrier 
impairment. 
Immune 
response is 
triggered by 
gluten and 
casein in some 
ASD children. 
Determination 
of antibodies 
titers to food 
antigens could 
be used to 
identify 
potential 
responders to 
the GFCF 
diet. 
Strengths: 
*Large sample 
size of ASD 
children. 
*Control 
groups 
present. 
*Concrete 
laboratory 
evidence 
utilized. 
 
Limitations: 
*Smaller 
control group. 
*Dietary 
intervention 
not 
professionally 
monitored. 
*Autism 
behavior 
symptoms not 
evaluated. 
AACN Level 
of Evidence: 
Grade B (Well 
designed 
study with 
consistent 
results). 
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Author 
(Year) 
Title 
Publication 
Purpose Design Sample Data 
Collection and 
Measurement 
Findings Strengths 
and 
Limitations 
Level of 
Evidence 
Mari-Bauset, S., 
Llopis-Gonzalez, 
A., Zazpe, I., 
Mari-Sanchis, 
A., Suarez-
Varela, M.M. 
(2016).  
 
Nutritional 
impact of a 
gluten-free 
casein-free diet 
in children with 
autism spectrum 
disorder. 
 
Journal of 
Autism and 
Developmental 
Disorders, 46, 
673-684. 
To determine 
whether children 
with ASD on a 
GFCF diet vs. a 
regular diet have 
lower 
anthropometric 
measures, varied 
nutrient intake, 
and are less likely 
to meet daily-
recommended 
intake values. 
Case-
control 
study. 
Children ages 
6-9 years old 
diagnosed 
with an ASD, 
severity not 
considered 
(n=105). 
Study group 
n=20 and 
control group 
n=85. 
Height and 
weight 
measurements 
utilized to 
calculate BMI. 
Caloric intake, 
macronutrients, 
and 
micronutrients 
compared 
between two 
groups. 
Healthy Eating 
Index utilized 
also to 
compare 
nutrients. 
Dietary 
Reference 
Intakes utilized 
to measure 
adequate or 
inadequate 
intake. 
ASD children 
on a GFCF 
diet had 
lower BMI’s 
than those on 
a regular diet. 
Vitamin and 
nutrient 
differences 
were noted 
between the 
two diets 
with GFCF 
kids being 
deficient in 
some 
nutrients and 
regular diet 
kids being 
deficient in 
others. 
Typically the 
GFCF diet 
group at a 
“healthier” 
diet than their 
counterparts. 
Strengths: 
*Children 
presented with 
similar 
characteristics 
in 
socioeconomic 
status, place of 
residence, 
ethnicity, and 
living 
conditions. 
*Children 
studied in 
parallel over 
same time 
period. 
 
Limitations: 
*Small sample 
size. 
*Only a 3-day 
food record 
was utilized. 
*GFCF diet 
not monitored 
professionally. 
*Autism 
behaviors or 
characteristics 
not mentioned 
in this study. 
AACN 
Level of 
Evidence: 
Grade C 
(Case-
control study 
with 
inconsistent 
results). 
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Author 
(Year) 
Title 
Publication 
Purpose Design Sample Data 
Collection and 
Measurement 
Findings Strengths 
and 
Limitations 
Level of 
Evidence 
Genius, S.J. & 
Lobo, R.A. 
(2014).  
 
Gluten 
sensitivity 
presenting as a 
neuropsychiatric 
disorder.  
 
Gastroenterology 
Research and 
Practice, 1-6. 
To provide a 
clinical review of 
gluten sensitivity 
as it relates to 
mental health and 
to examine 
pathophysiological 
mechanisms for 
the 
neuropsychiatric 
symptoms 
associated with 
gluten sensitivity 
in some patients. 
Case-
report. 
A 23-year-old 
female with a 
longstanding 
history of 
auditory and 
visual 
hallucinations. 
Symptom 
review 
following a 
regular diet, 
gluten free 
diet, and after 
accidental 
gluten 
exposure. 
The subject 
experienced 
extreme 
auditory and 
visual 
hallucinations 
throughout her 
entire life as 
well as being 
diagnosed 
with irritable 
bowel 
syndrome. In 
college she 
decided to 
independently 
eliminate 
gluten from 
diet with 
complete 
resolution of 
symptoms. 
Symptoms 
would return 
within hours 
of any slight 
accidental 
gluten 
exposure and 
last 24-72hrs. 
Strengths: 
*Symptoms 
completely 
resolved after 
gluten 
elimination- 
providing 
clear 
correlation. 
*Subject was 
not 
cognitively 
delayed and 
able to give 
accurate 
description of 
symptoms. 
 
Limitations: 
*No concrete 
laboratory 
data utilized 
as subject 
refused. 
*Physician 
monitoring 
not 
mentioned. 
AACN 
Level of 
Evidence: 
Grade E 
(Single case-
report 
without 
concrete 
evaluation 
methods). 
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Author 
(Year) 
Title 
Publication 
Purpose Design Sample Data 
Collection 
and 
Measurement 
Findings Strengths 
and 
Limitations 
Level of 
Evidence 
Herbert, M.R., 
Buckley, J.A. 
(2013). 
 
Autism and 
diet therapy: 
case report 
and review of 
the literature. 
 
Journal of 
Child 
Neurology, 
28(8), 975-
982. 
To provide a 
report of a 
child who 
experienced 
regressive 
autism at the 
age of 4, 
subsequently 
placed on a 
gluten-free 
casein-free 
diet, and 
followed into 
teenage years.  
Case-report. A 13-year-old 
child who 
experienced 
regressive 
autism at age 
4 and later 
diagnosed 
with epilepsy 
at age 11 with 
limited 
response to 
typical 
interventions. 
The 
Childhood 
Autism Rating 
Scale (CARS) 
was utilized to 
score autism 
severity. 
Symptoms 
and 
interventions 
were detailed 
and recorded 
in 
chronological 
order. 
Autism 
symptoms 
significantly 
improved on a 
GFCF diet and 
after puberty 
seizure 
activity was 
significantly 
improved on a 
GFCF 
ketogenic diet. 
Strengths: 
*Symptoms and 
interventions are 
detailed 
chronologically.  
*EEG performed 
pre and post 
further dietary 
intervention. 
*CARS scores 
noted pre and 
post 
interventions. 
 
Limitations: 
*Cause of 
significant 
regression into 
autism in a 
previously 
neurotypical 4-
year-old is not 
mentioned. 
*Biomedical 
supplements 
were also being 
utilized and 
changed 
throughout 
treatment. 
*Information 
source not 
mentioned. 
AACN Level 
of Evidence: 
Grade E 
(Single case-
report with 
unknown 
source of 
information). 
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Author 
(Year) 
Title 
Publication 
Purpose Design Sample Data 
Collection 
and 
Measurement 
Findings Strengths 
and 
Limitations 
Level of 
Evidence 
Genius, S.J., 
Bouchard, 
T.P. (2010). 
 
Celiac disease 
presenting as 
autism. 
 
Journal of 
Child 
Neurology, 
25(1), 114-
119. 
To describe a 
case where a 
5-year-old boy 
presented with 
severe autism, 
later 
diagnosed 
with Celiac 
Disease whose 
autism 
symptoms 
resolved 
following a 
gluten-free 
diet. 
Case-report. A 5-year-old 
boy diagnosed 
with severe 
autism at age 3 
who also 
experienced 
multiple 
abnormal 
gastrointestinal 
symptoms.  
Symptom 
review and 
parental report 
before and 
after dietary 
interventions. 
After 3 
months 
following a 
gluten-free 
diet, the child 
is 
mainstreamed 
back into a 
regular 
education 
classroom 
without any 
individualized 
special 
education, and 
his autism 
symptoms 
have 
disappeared. 
Strengths: 
*Concrete 
laboratory 
data utilized. 
 
Limitations: 
*Source of 
information 
unknown. 
*Follow up 
biochemical 
nutritional 
testing 
declined by 
parents due to 
resolution of 
symptoms. 
AACN Level 
of Evidence: 
Grade E 
(Single case-
report with 
unknown 
source of 
information). 
 
 
  
  
 
